Search

everythinglearnresearchcommunity

for

Search:↓

Intravenous calcium therapy is a safe and effective treatment for a rare type of rickets.

Two rare genetic diseases cause severe rickets in children due to defects in vitamin D metabolism.

A 3-year-old with vitamin D-resistant rickets and severe hair loss died despite treatment, highlighting the need for improved management of the condition.

A child with rickets and hair loss might have a rare type of rickets that doesn't improve much with usual vitamin D and calcium treatment.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Mutations in the vitamin D receptor cause hereditary vitamin D-resistant rickets, leading to poor bone health and requiring high calcium doses for treatment.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

Three siblings with a genetic form of rickets showed different symptoms of the disease.

A dog's skin calcification condition resolved without treatment after a bacterial infection.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Some people have genetic mutations that make them resistant to vitamin D, leading to rickets even with enough vitamin D intake.

A vitamin D receptor mutation causes rickets and affects immune responses.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Sarcoidosis can cause scarring hair loss on the scalp, which is rare.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Monitoring for adverse effects in clinical treatments is crucial.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

The combination of zinc sulfate and calcium pantothenate effectively controls early-stage hair loss.

Three sessions of PRP mixed with calcium chloride effectively treated alopecia.

High-dose methotrexate can cause severe skin and nail issues.

New therapies for burn wounds show promise in reducing pain, infection risk, and improving healing and physical outcomes.